Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

IDACIO

ADALIMUMAB-AACF

Standard Dose
40MG/0.8ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview IDACIO is listed in Drugs@FDA under application 761255 (BLA).

Marketing status: Prescription Active ingredient ADALIMUMAB-AACF Form and strength INJECTABLE;SUBCUTANEOUS - 40MG/0.8ML Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2025-12-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview IDACIO is listed in Drugs@FDA under application 761255 (BLA). Marketing status: Prescription Active ingredient ADALIMUMAB-AACF Form and strength INJECTABLE;SUBCUTANEOUS - 40MG/0.8ML Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2025-12-23 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.